The Anxiety and Depression in Rheumatoid Arthritis Patients Treating with Disease-Modifying Anti-Rheumatic Drugs during the COVID-19 Pandemic

OBJECTIVE: Anxiety and depression are associated with the risk of illness, presence of physical symptoms, and poor health in the COVID-19 epidemic. Our aim is to assess the severity of anxiety and depression in rheumatoid arthritis (RA) patients treated with disease-modifying anti-rheumatic drugs du...

Descripción completa

Detalles Bibliográficos
Autores principales: Sargın, Gökhan, Baygin, Huseyin, Senturk, Taskin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Mediterranean Journal of Rheumatology (MJR) 2022
Materias:
Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075372/
https://www.ncbi.nlm.nih.gov/pubmed/37034363
http://dx.doi.org/10.31138/mjr.33.4.430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075372/
https://www.ncbi.nlm.nih.gov/pubmed/37034363
http://dx.doi.org/10.31138/mjr.33.4.430

Ejemplares similares